During the nine months of 2026, the range of drugs in Russia decreased by 1.1% in annual terms, to 14.45 thousand product items, Kommersant writes, citing data from the analytics company RNC Pharma. Negative dynamics were recorded for the first time since 2021. The decrease affected both foreign manufacturers, whose supply decreased by 97 items, and Russian companies, who reduced their selection by 65 items - for the first time in the last ten years.